Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
The 1st International Workshop on CAR-T (iwCAR-T) took place on October 11–13, 2019, in Miami, FL. The inaugural meeting brought together leading experts in the field to discuss the considerations of this emerging immunotherapy for hematological malignancies.
These e-learning webcasts will help consolidate your knowledge on the key themes surrounding CAR T-cell therapy, including toxicity issues, the evolution of cellular therapies, overcoming resistance mechanisms, as well as its use in CLL, acute leukemias, multiple myeloma, and lymphoma.
You can view each presentation simply by clicking on its title.
Please note that presentations from Session V are unavailable due to unpublished data.
▶ Axicabtagene ciloleucel for large B-cell lymphoma
▶ Update on TRANSCEND NHL-001: lisocabtagene maraleucel
▶ BMT vs CAR-T in second-line DLBCL
▶ CAR T-cell approaches to T-cell lymphoma
▶ CAR T-cell therapy in follicular lymphoma
▶ Universal SLAMF7-specific CAR T-cells (UCARTCS1) for multiple myeloma
▶ New targets and technologies for CAR-T: moving beyond ‘state-of-the-art’
▶ LCAR-B38M/JNJ-4528: global CAR-T development perspectives
Tonia Nesheiwat & Jordan Schecter
▶ Allogeneic CAR T-cells – a reality?
Keep up to date with all the latest news with our monthly newsletter